Completed
Topics
This workshop examined the impact of and investment in the use of genetic and genomic data in drug development. The goal of the workshop was to discuss how genomic and genetic data have been and will be used in the drug development process to improve aspects such as target identification, clinical trial design, pharmacogenomics approaches, biomarker development and understanding disease biology.
Featured publication
Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary
Proceedings
·2012
The number of new drug approvals has remained reasonably steady for the past 50 years at around 20 to 30 per year, while at the same time the total spending on health-related research and development has tripled since 1990. There are many suspected causes for this trend, including increases in regul...
View details